Effects of age, gender, and immunosuppressive agents on in vivo toll-like receptor pathway responses

Human Immunology

Volumn 71, Issue 4, 2010, Pages 372-376

  Khan, Niamat ^a   Summers, Colin W ^a   Helbert, Matthew R ^a   Arkwright, Peter D ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Autoimmunity; Cytokines; Gender; Immunosuppressive drugs; TLR

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; BETA INTERFERON; CYCLOSPORIN; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; INTERFERON; INTERLEUKIN 6; LOXORIBINE; TACROLIMUS; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG PROTEIN BINDING; DRUG TARGETING; FEMALE; HUMAN; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; LIGAND BINDING; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BLOOD CELLS; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; SEX FACTORS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 77950521851     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.01.018     Document Type: Article

References (30)

1. Akira S. TLR signaling. Curr Top Microbiol Immunol 2006, 311:1-16.
2. Kaisho T., Akira S. Toll-like receptor function and signaling. J Allergy Clin Immunol 2006, 117:979-987.
3. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 1998, 282:2085-2088.
4. Skerrett S.J., Liggitt H.D., Hajjar A.M., Wilson C.B. Cutting edge: Myeloid differentiation factor 88 is essential for pulmonary host defense against Pseudomonas aeruginosa but not Staphylococcus aureus. J Immunol 2004, 172:3377-3381.
5. Picard C., Puel A., Bonnet M., Ku C.L., Bustamante J., Yang K., et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 2003, 299:2076-2079.
6. Ku C.L., Picard C., Erdos M., Jeurissen A., Bustamante J., Puel A., et al. IRAK-4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease. J Med Genet 2006, 44:16-23.
7. Doffinger R., Smahi A., Bessia C., Geissmann F., Feinberg J., Durandy A., et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappa-B signaling. Nat Genet 2001, 27:277-285.
8. Casrouge A., Zhang S.Y., Eidenschenk C., Jouanguy E., Puel A., Yang K., et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 2006, 314:308-312.
9. Meng G., Rutz M., Schiemann M., Metzger J., Grabiec A., Schwandner R., et al. Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes. J Clin Invest 2004, 113:1473-1481.
10. Joosten L.A., Koenders M.I., Smeets R.L., Heuvelmans-Jacobs M., Helsen M.M., Takeda K., et al. Toll-like receptor 2 pathway drives streptococcal cell wall-induced joint inflammation: Critical role of myeloid differentiation factor 88. J Immunol 2003, 171:6145-6153.
11. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 2006, 6:823-835.
12. Renshaw M., Rockwell J., Engleman C., Gewirtz A., Katz J., Sambhara S. Cutting edge: Toll-like receptor expression and function in aging. J Immunol 2002, 169:4697-4701.
13. Auphan N., DiDonato J.A., Rosette C., Helmberg A., Karin M. Immunosuppression by glucocorticoids: Inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995, 270:286-290.
14. Almawi W.Y., Melemedjian O.K. Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids. J Mol Endocrinol 2002, 28:69-78.
15. Ito K., Chung K.F., Adcock I.M. Update on glucocorticoid action and resistance. J Allergy Clin Immunol 2006, 117:522-543.
16. De Bosscher K., Van den Berghe W., Vermeulen L., Plaisance S., Boone E., Haegeman G. Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc Natl Acad Sci USA 2000, 97:3919-3924.
17. Berghofer B., Frommer T., Haley G., Fink L., Bein G., Hackstein H. TLR ligands induce higher IFN-alpha production in females. J Immunol 2006, 177:2088-2096.
18. Jurk M., Kritzler A., Schulte B., Tluk S., Schetter C., Krieg A.M., et al. Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T-rich phosphorothiate oligodeoxynucleotides. Eur J Immunol 2006, 36:1815-1826.
19. Klein S. Host factors mediating sex differences in viral infections. Gend Med 2005, 2:197-207.
20. Beeson P.B. Age and sex associations of 40 autoimmune diseases. Am J Med 1994, 96:457-462.
21. Marodi L. Innate cellular immune responses in newborns. Clin Immunol 2006, 118:137-144.
22. van Duin D., Mohanty S., Thomas V., Ginter S., Montgomery R.R., Fikrig E., et al. Age-associated defect in human TLR-1/2 function. J Immunol 2007, 178:970-975.
23. McDonald J.W., Feagan B.G., Jewell D., Brynskov J., Stange E.F., MacDonald J.K. Cyclosporine for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2005, (2). CD000297.
24. Couriel D., Saliba R., Hicks K., Ippoliti C., de Lima M., Hosing C., et al. Tumor necrosis factor-alpha blockade for the treatment of acute GVHD. Blood 2004, 104:649-654.
25. Symmons D.P., Silman A.J. The world of biologics. Lupus 2006, 15:122-126.
26. Umezawa K., Chaicharoenpong C. Molecular design and biological activities of NF-kappaB inhibitors. Mol Cells 2002, 14:163-167.
27. Kim J.H., Jeong J.H., Jeon S.T., Kim H., Ock J., Suk K., et al. Decursin inhibits induction of inflammatory mediators by blocking nuclear factor-kappaB activation in macrophages. Mol Pharmacol 2006, 69:1783-1790.
28. Blanco P., Palucka A.K., Gill M., Pascual V., Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythromatosus. Science 2001, 294:1540-1543.
29. Roelofs M.F., Wenink M.H., Brentano F., Abdollahi-Roodsaz S., Oppers-Walgreen B., Barrera P., et al. Type I interferons might form the link between Toll-like receptor (TLR 3/7 and TLR4 mediated synovial inflammation in rheumatoid arthritis (RA). Ann Rheum Dis 2009, 68:1486-1493.
30. Sacre S.M., Lo A., Gregory B., Simmonds R.D., Williams L., Feldmann M., et al. Inhibitors of TLR8 reduce TNF production from human rheumatoid synovial membrane cultures. J Immunol 2008, 181:8002-8009.